Wuhan sea special biological pharmaceutical company limited. is by Wuhan University, 6 home shareholders units Yu November 2000 common launched established of a to national category new biological products "gold Jie Lu--injection with rat neural growth factor" for leading products, to created first-class of treatment nervous system disease drug industry base for target of set research and development, and production, and marketing for one of modernization high-tech biological pharmaceutical enterprise. the company registered capital of 60 million Yuan, registered in Wuhan economic and technological development zone of Green Island Science and Technology Park, the production range of biological products (lyophilized mouse nerve growth factor for injection injection, Lyophilized Powder for Injection of anti-HBV transfer factor for injection), Lyophilized Powder for Injection, small volume injection.
the company has first-class production base. factory covers an area of 138,000 square meters green area of 108,000 square meters, construction area of 17,000 square meters. their overall plan is designed by internationally renowned architects, divided into administrative regions, production areas, production assistant, research and development centres and cultural and sports activities. the plant layout reasonable, facilities, beautiful environment, Evergreen. company existing meet national GMP certification standard of production plant 6,600 square, and production and quality and the public device instrument more than 200 more than Taiwan (sets), which has from Japan, and United States introduced of value tens of millions of Yuan of small capacity injection agent filling seal machine line, and frozen powder injection min loaded online, and large frozen vacuum drying machine, and frozen centrifugal machine and efficient liquid phase color spectrum instrument, and CO2 training box, advanced of production, and experimental, and detection device., aseptic room equipped with first-class experimental centre, as well as commensurate with the production of water, electricity, steam, gas, refrigeration facilities, sewage treatment plant and other facilities, with an annual output of 15 million, 30 million of lyophilized powder for injection of small capacity injection production scale. the
company has a high management level and the strong talent. the company strictly in accordance with the joint-stock company standard operation and General Manager responsibility system under the leadership of the Board, adopt modern enterprise management mode, in strict accordance with the GMP requirements for drugs production and total quality management. the company's existing staff of 188 people, brings together a large number of domestic high-quality management personnel and technicians, 40% of which is the senior professional and technical personnel, University degree or above accounted for 76%, and the famous academician, University Professor working at enterprise.
the company has unique advantages. leading product "Jin Jie Lu----mouse nerve growth factor for injection" is a national kind of new biological products, for global Government approved the listing of the first class of nerve injury disease medication. the project derived from the outcome of the 1986 Nobel Prize in Physiology or medicine, the company will successfully its nearly 50 years of research results into industrial products, and obtained the national torch program and support of national innovation fund projects. the company also has hepatitis b treatment anti-HBV transfer factor for injection, is a local Hemostatic agents quickly Thrombin, of the national essential medicines for cardio-cerebral vascular diseases have a significant effect of defibrase of drugs more than more than 20 products.
the company attaches great importance to the development of new products and technological innovation. in addition to the existing plant of biological products and biochemical plants outside, the company also plans to build 3 years genes and medicine workshop. rely on their own talents and in close cooperation with the domestic and foreign famous educational institutions, research institutions, new product research and development continued to make encouraging results. currently has entered clinical stage and the is development stage of new products has: has obtained clinical approved of national drugs anti-TB special specific transfer factor, and gene restructuring people white cell between pigment -10 (rhlL-10), and new restructuring people neural nutrition factor, and restructuring people organization type fiber dissolved enzyme original activated real (rht-PA) and the natural drug seven leaves SOAP glycosides sodium,, market potential value in 8 billion Yuan Yuan above.undefined in order to benefit from more efficient update far brings together pharmaceutical frontiers in terms of information, integrating social resources, the company will take the road of development.